Free Trial

Knights of Columbus Asset Advisors LLC Buys 49,979 Shares of Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Key Points

  • Knights of Columbus Asset Advisors LLC significantly increased its stake in Procter & Gamble by 796.9% during Q1, acquiring 49,979 shares to bring its holdings to 56,251 shares valued at approximately $9.59 million.
  • Procter & Gamble recently reported earnings of $1.54 per share for the quarter, slightly exceeding analysts' estimates, with a 2.1% decline in year-over-year revenue.
  • The company declared a quarterly dividend of $1.0568 per share, reflecting an annualized payout of $4.23 and a yield of 2.66%.
  • Five stocks we like better than Procter & Gamble.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Knights of Columbus Asset Advisors LLC increased its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 796.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 56,251 shares of the company's stock after acquiring an additional 49,979 shares during the period. Knights of Columbus Asset Advisors LLC's holdings in Procter & Gamble were worth $9,586,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Navigoe LLC bought a new position in shares of Procter & Gamble in the fourth quarter worth approximately $31,000. Capital A Wealth Management LLC bought a new position in Procter & Gamble in the 4th quarter valued at approximately $31,000. Hoey Investments Inc. lifted its position in Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after acquiring an additional 148 shares in the last quarter. 10Elms LLP bought a new position in Procter & Gamble in the 4th quarter valued at approximately $34,000. Finally, Mizuho Securities Co. Ltd. lifted its position in Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $158.82 on Friday. The stock's fifty day moving average is $161.12 and its two-hundred day moving average is $164.24. The company has a market capitalization of $372.37 billion, a PE ratio of 25.21, a price-to-earnings-growth ratio of 4.51 and a beta of 0.40. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47. Procter & Gamble Company has a 52 week low of $151.90 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The business had revenue of $19.78 billion during the quarter, compared to analyst estimates of $20.42 billion. During the same period in the previous year, the company posted $1.52 EPS. Procter & Gamble's revenue was down 2.1% on a year-over-year basis. As a group, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble's payout ratio is 67.14%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the transaction, the chief executive officer directly owned 51,965 shares of the company's stock, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the business's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the transaction, the insider directly owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on PG shares. UBS Group lowered their price objective on Procter & Gamble from $186.00 to $180.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Redburn Atlantic downgraded shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target on the stock. in a research report on Thursday, May 1st. Barclays increased their price target on shares of Procter & Gamble from $160.00 to $161.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Finally, Evercore ISI reiterated an "in-line" rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Eight analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $176.24.

Check Out Our Latest Stock Analysis on Procter & Gamble

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines